PlumX Metrics
Embed PlumX Metrics

Improving Patient Safety Through Access to Sugammadex in the PACU Setting

2024
  • 0
    Citations
  • 4
    Usage
  • 0
    Captures
  • 0
    Mentions
  • 0
    Social Media
Metric Options:   Counts1 Year3 Year

Metrics Details

Conference Paper Description

Prior to development of Sugammadex the frequency of residual neuromuscular paralysis in PACU has been documented to range from 4-50%. Residual paralysis is associated with many postoperative complications including hypoxia and respiratory failure. Following an incidence of inadequate muscular paralysis reversal leading to respiratory decompensation in PACU, we instituted a change in the way providers have access to Sugammadex within this setting. Sugammadex vials are now stocked within PACU Omnicell for urgent access and within the crash cart for emergent need. Providers have given positive feedback regarding this institutional change

Provide Feedback

Have ideas for a new metric? Would you like to see something else here?Let us know